•Bladder cancer survivorship
•Survivor burdens unmet needs
•CPEX testing in bladder cancer
•Management of low, intermediate and high risk bladder cancer
•Neoadjuvant chemotherapy in muscle invasive bladder cancer
•Multimodal therapy for muscle invasive bladder cancer
•None Muscle invasive bladder cancer- chemotherapy or resection
•Muscle invasive bladder cancer- open, laparoscopic or roboticG3 NMIBC- BCG versus cystectomy
•Role of immunotherapy in bladder cancer
•Robotic Surgery and bladder cancer
•Quality of life post Cystectomy
•The Neobladder and Quality of life
•Ileal conduit versus neobladder, which is better?
•Quality of life post NMIBC or BCG
•Rarc technical tips and tricks
•Robotic Surgery and resection
•Robotic radical cystectomy and PLND
•Robotic cystectomy and sentinal node mapping
•Robotic cystectomy and neobladder formation
•Robotic cystectomy and enhanced recovery
•Robotic radical cystectomy, pain and enhanced recovery
•Enhanced recovery and hypoalbumineamia
•The Robotic approach to redo surgery
•Robotic cystectomy and ureteric strictures
•BCG and cystectomy
•BCG and secondary malignancy.
This book covers the latest advances in non-muscle invasive bladder cancer care. It provides a review of the available evidence base for the efficacy of a range of therapeutic techniques, diagnostic procedures and risk factors.
Management of Non-Muscle Invasive Bladder Cancer features detailed guidance in uniformly formatted chapters on how to properly apply a range of available therapeutic treatments relevant for patient care. It is a valuable resource for all trainee and practising medical professionals who treat these patients.
• Provides a holistic overview of bladder cancer
• Includes an evidence base for clinicians providing survivorship care
• Discusses the latest therapy developments including neoadjuvant chemotherapy